Literature DB >> 28477248

Fluoxetine, an Antidepressant Drug, Inhibited Cigarette Smoke-Induced Pulmonary Inflammation and Apoptosis in Rats.

Zhiyong Cai1, Jindi Liu2, Hongliang Bian3, Jinlan Cai1, Qing Jin1, Jijing Han1.   

Abstract

The present study was designed to evaluate the anti-inflammatory effect of fluoxetine (Flu) against cigarette smoke (CS)-induced chronic obstructive pulmonary disease (COPD) in rats. Forty male Sprague-Dawley (SD) rats were randomly assigned to five groups: control group, CS group, dexamethasone (2 mg/kg) group, and flu (2 mg/kg). H&E staining demonstrated that Flu inhibited CS-induced pathological injury. In addition, Flu could restore the levels of superoxide dismutase (SOD) and malondialdehyde (MDA) in serum. Flu also inhibited the levels of cytokines including tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β). Furthermore, flu significantly inhibited the protein levels of TLR/NF-κB and apoptosis pathway in CS-induced rats. Our findings suggested that flu might effectively ameliorate the progression of COPD via inflammation and apoptosis pathway in rats.

Entities:  

Keywords:  COPD; apoptosis; fluoxetine; inflammation

Mesh:

Substances:

Year:  2017        PMID: 28477248     DOI: 10.1007/s10753-017-0580-y

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  25 in total

Review 1.  Recognition of microbial infection by Toll-like receptors.

Authors:  Elizabeth Kopp; Ruslan Medzhitov
Journal:  Curr Opin Immunol       Date:  2003-08       Impact factor: 7.486

2.  Toll-like receptor signaling pathways.

Authors:  Gregory M Barton; Ruslan Medzhitov
Journal:  Science       Date:  2003-06-06       Impact factor: 47.728

Review 3.  Murine models of COPD.

Authors:  G G Brusselle; K R Bracke; T Maes; A I D'hulst; K B Moerloose; G F Joos; R A Pauwels
Journal:  Pulm Pharmacol Ther       Date:  2005-08-03       Impact factor: 3.410

4.  Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010.

Authors:  Gonghuan Yang; Yu Wang; Yixin Zeng; George F Gao; Xiaofeng Liang; Maigeng Zhou; Xia Wan; Shicheng Yu; Yuhong Jiang; Mohsen Naghavi; Theo Vos; Haidong Wang; Alan D Lopez; Christopher J L Murray
Journal:  Lancet       Date:  2013-06-08       Impact factor: 79.321

5.  Protective effect of platycodin D on liver injury in alloxan-induced diabetic mice via regulation of Treg/Th17 balance.

Authors:  Tong Chen; Jin Gao; Pengjun Xiang; Yongde Chen; Jing Ji; Peng Xie; Hui Wu; Wei Xiao; Yidan Wei; Shumin Wang; Li Lan; Hui Ji; Tianhua Yan
Journal:  Int Immunopharmacol       Date:  2015-04-15       Impact factor: 4.932

6.  The protective effect of CDDO-Me on lipopolysaccharide-induced acute lung injury in mice.

Authors:  Tong Chen; Yi Mou; Jiani Tan; Linlin Wei; Yixue Qiao; Tingting Wei; Pengjun Xiang; Sixun Peng; Yihua Zhang; Zhangjian Huang; Hui Ji
Journal:  Int Immunopharmacol       Date:  2015-01-19       Impact factor: 4.932

7.  Effect of cilomilast (Ariflo) on TNF-alpha, IL-8, and GM-CSF release by airway cells of patients with COPD.

Authors:  M Profita; G Chiappara; F Mirabella; R Di Giorgi; L Chimenti; G Costanzo; L Riccobono; V Bellia; J Bousquet; A M Vignola
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

8.  RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation.

Authors:  Etienne Meylan; Kim Burns; Kay Hofmann; Vincent Blancheteau; Fabio Martinon; Michelle Kelliher; Jürg Tschopp
Journal:  Nat Immunol       Date:  2004-04-04       Impact factor: 25.606

9.  Protective Effect of Astragaloside IV Against Paraquat-Induced Lung Injury in Mice by Suppressing Rho Signaling.

Authors:  Tong Chen; Ruoning Wang; Wenjiao Jiang; Huimin Wang; Ang Xu; Guo Lu; Yi Ren; Yangmei Xu; Yangyang Song; Shoulei Yong; Hui Ji; Zhanqiang Ma
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

10.  Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway.

Authors:  Qi Jiang; Min Yi; Qianqian Guo; Ciman Wang; Huimin Wang; Shanshan Meng; Chao Liu; Yeliu Fu; Hui Ji; Tong Chen
Journal:  Int Immunopharmacol       Date:  2015-10-24       Impact factor: 4.932

View more
  2 in total

1.  Xiaoqinglong Decoction Protects the Lungs of AECOPD Mice through the AMPK/mTOR Signaling Pathway.

Authors:  Qingsong Huang; Hongjing Yang; Chuantao Zhang; Jianying Wu; Wei Xiao; Zhu Zeng
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-04       Impact factor: 2.629

2.  Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection.

Authors:  Justin Fortune Creeden; Ali Sajid Imami; Hunter M Eby; Cassidy Gillman; Kathryn N Becker; Jim Reigle; Elissar Andari; Zhixing K Pan; Sinead M O'Donovan; Robert E McCullumsmith; Cheryl B McCullumsmith
Journal:  Biomed Pharmacother       Date:  2021-02-25       Impact factor: 6.529

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.